SMYRNA, Ga., April 1 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (the “Company”), an Atlanta-based biopharmaceutical company, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities Commission for a best efforts offering to sell up to $40.0 million of units consisting of one share of common stock and a warrant to purchase 0.20 shares of common stock. The offering anticipates including shares of common stock to be sold by selling stockholders.
The placement agent for the offering is Global Hunter Securities LLC. A copy of the preliminary prospectus may be obtained from Tim Monfort, Head of Equity Capital Markets, 444 Madison Ave 40th Floor, New York, NY 10022, (212) 400-4806.
A REGISTRATION STATEMENT RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION BUT HAS NOT YET BECOME EFFECTIVE. THESE SECURITIES MAY NOT BE SOLD NOR MAY OFFERS TO BUY BE ACCEPTED PRIOR TO THE TIME THE REGISTRATION STATEMENT BECOMES EFFECTIVE.
GeoVax Labs, Inc.